Anzeige
Mehr »
Samstag, 06.06.2026 - Börsentäglich über 12.000 News
UraniumX startet heiß ersehntes Bohrprogramm mitten im neuen Uran-Superzyklus
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P5KA | ISIN: CA75671E1097 | Ticker-Symbol: 4YX
Frankfurt
05.06.26 | 08:09
0,022 Euro
+10,00 % +0,002
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
RED LIGHT HOLLAND CORP Chart 1 Jahr
5-Tage-Chart
RED LIGHT HOLLAND CORP 5-Tage-Chart
RealtimeGeldBriefZeit
0,0170,03305.06.

Aktuelle News zur RED LIGHT HOLLAND Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoRed Light Holland Corp: Red Light Holland's psilocybin selected for UCSF study2
DoRed Light Holland Corp.: Red Light Holland Announces Filament Health's PEX010 Drug Candidate, the Standardized and Patented Natural Psilocybin Trusted Across 80+ Studies Globally, Selected by UCSF for Study Probing Preclinical Alzheimer's Markers347Filament Health will supply its standardized, patented PEX010 botanical psilocybin drug candidate, produced using proprietary extraction and stabilization methods to an independently sponsored UCSF...
► Artikel lesen
25.05.Red Light Holland Corp: Red Light expands NZ psilocybin supply partnership4
25.05.Red Light Holland Corp.: Red Light Holland Expands New Zealand Partnership with Allu Therapeutics to Advance Access to Filament Health's GMP-Compliant PEX010 Botanical Psilocybin Drug Candidate442The expanded agreement adds Filament Health, a wholly owned subsidiary of Red Light Holland, as a supplying affiliate and introduces a GMP-compliant standardized microdose format of PEX010 supported...
► Artikel lesen
14.05.Red Light Holland Corp.: Red Light Holland's Wholly Owned Subsidiary, Filament Health, Advances PEX010 Clinical Footprint with New Canadian Academic Studies in Palliative Care, Bipolar II Depression, and Healthy Adult Mechanism Research454Toronto, Ontario--(Newsfile Corp. - May 14, 2026) - Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) (FSE: 4YX) ("Red Light" or the "Company") is an Ontario based organization advancing innovation...
► Artikel lesen
14.05.Red Light Holland Corp: Red Light Holland shareholders approve name change3
13.05.Red Light Holland Corp.: Red Light Holland Announces Shareholder Approval of Name Change and Announces Voting Results from 2026 Annual General and Special Meeting of Shareholders526Toronto, Ontario--(Newsfile Corp. - May 13, 2026) - Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) (FSE: 4YX) ("Red Light Holland" or the "Company") is pleased to announce that shareholders...
► Artikel lesen
08.05.Red Light Holland Corp.: Red Light Holland Highlights Publication of Randomized Clinical Trial Showing a Single Dose of Psilocybin Reduced Cocaine Use, with Filament Health Holding the Exclusive License to the Data and Intellectual Property447Peer-reviewed results published yesterday (May 7, 2026) in JAMA Network Open demonstrate that a single dose of psilocybin meaningfully reduced cocaine use in adults with cocaine use disorder over...
► Artikel lesen
RED LIGHT HOLLAND Aktie jetzt für 0€ handeln
07.05.Red Light Holland Corp: Red Light expands PEX010 distribution in North America4
07.05.Red Light Holland Corp.: Red Light Holland's Wholly Owned Subsidiary, Filament Health, Expands Distribution of PEX010 Across Canadian and U.S. Research Institutions444Toronto, Ontario--(Newsfile Corp. - May 7, 2026) - Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) (FSE: 4YX) ("Red Light" or the "Company") is an Ontario-based organization advancing innovation...
► Artikel lesen
05.05.Red Light Holland Corp: Red Light plans rebranding, including name change3
30.04.Red Light Holland Corp: Red Light Holland closes Filament Health acquisition5
30.04.Red Light Holland Corp.: Red Light Holland Completes Acquisition of Filament Health, Creating a Global Leader in Psychedelic Drug Development, Commercialization and Distribution436Establishes a vertically integrated platform spanning pharmaceutical-grade botanical drug development and global consumer distributionAdds Filament's extensive intellectual property portfolio, including...
► Artikel lesen
29.04.Red Light Holland Corp: Red Light Holland receives court OK for Filament buy5
29.04.Red Light Holland Corp.: Red Light Holland Announces Filament Health Obtains Final Order for Proposed Arrangement366Toronto, Ontario--(Newsfile Corp. - April 29, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") and Filament Health Corp. (OTC: FLHLF) ("Filament")...
► Artikel lesen
27.04.Red Light Holland Corp: Red Light target Filament receives shareholder approval2
27.04.Red Light Holland Corp.: Red Light Holland Announces Filament Health Shareholder Approval of Acquisition373Toronto, Ontario--(Newsfile Corp. - April 27, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light") and Filament Health Corp. (OTC: FLHLF) ("Filament") are pleased...
► Artikel lesen
24.04.Red Light Holland Corp: Red Light target talks PEX010 clinical supply shipments6
24.04.Red Light Holland Corp.: Red Light Holland Showcases Growing Clinical Demand for Filament Health's PEX010 with New and Repeat University Shipments432Toronto, Ontario--(Newsfile Corp. - April 24, 2026) - Red Light Holland Corp. (CSE: TRIP) (OTCQB: TRUFF) (FSE: 4YX) ("Red Light" or the "Company") is pleased to highlight continued expansion and...
► Artikel lesen
21.04.Red Light Holland Corp: Red Light notes psychedelic policy shift for Kala Bio30
Weiter >>
51 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1